RNA-Guided Gene Drives for Site-Specific Genome Editing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current gene drive technologies are limited in their site specificity and difficulty in expression across various organisms, making it challenging to develop gene drives that can target any desired gene and be used across a broad spectrum of organisms.

Innovation Solution

The development of RNA-guided gene drives, which involve a foreign nucleic acid sequence stably introduced into a germline cell, encoding RNA-guided DNA binding proteins and guide RNAs that co-localize to specific DNA sites, allowing for site-specific insertion and expression, enabling the creation of transgenic organisms with desired traits that can be introduced into wild-type populations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If homing endonuclease based gene drives are used, then gene drive function is achieved, but site specificity is limited

Engineering Contradiction:
Improvesite specificityVSAvoidorganism applicability
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The patent applies CRISPR-Cas9 technology, a universal system originally developed for bacterial immunity, to create gene drives across diverse organisms including mosquitoes, mice, and other species. The guide RNA can be programmed to target any desired gene sequence, making the system universally applicable across different organisms while maintaining high site specificity through RNA-DNA complementarity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If traditional gene drive systems are used, then gene drive capability is achieved, but difficulty in expression across various organisms exists

Engineering Contradiction:
Improveorganism spectrumVSAvoidexpression difficulty
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent replaces complex organism-specific molecular mechanisms with the RNA-guided CRISPR-Cas9 system. Instead of relying on organism-specific homing endonuclease systems that are difficult to engineer and express, the invention uses a programmable RNA guide to direct Cas9 nuclease activity, simplifying the manufacturing and expression process across diverse organisms while maintaining precise gene targeting capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If RNA guided gene drives are used, then site specificity and efficiency are improved, but system complexity increases

Engineering Contradiction:
ImproveDNA editing specificityVSAvoidgene drive system structure
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent segments the gene drive system into distinct functional modules: the Cas9 nuclease component, the guide RNA component with its spacer and stem-loop regions, and the cargo gene component. This modular segmentation allows each component to be independently optimized and assembled, reducing overall system complexity while maintaining high DNA editing specificity through the programmed RNA-DNA pairing mechanism.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the production of a population of transgenic organisms with desired traits, enabling the spread of genetic modifications through wild populations, controlling gene flow, suppressing or increasing target populations, and reducing the spread of diseases like malaria by editing genomic DNA with high specificity and efficiency.

Implementation Method 1

The RNA is complementary to a target DNA sequence on a chromosome. The RNA guided DNA binding protein and the RNA co-localize to the target DNA

Methodology Applied
Scientific EffectComplementary base pairing:

Data Source

PatentUS10526618B2RNA-guided gene drives
Publication Date: 2020.01.07 PRESIDENT & FELLOWS OF HARVARD COLLEGE
  • US10526618B2 patent drawing
  • US10526618B2 patent drawing
  • US10526618B2 patent drawing

AI summary

RNA guided Cas9 gene drives and method for their use are disclosed.